Sign up
Pharma Capital

WideCells takes CellPlan to Spain

João Andrade, chief executive of WideCells Group PLC (LON:WDC), tells Proactive they're to launch their stem cell healthcare insurance plan in Spain following the product’s debut in the UK and alongside the imminent roll-out in Brazil.

The local agent for the CellPlan, which costs £170 a year, will be a company called Stem Cell Banco Celulas Madre, a provider of stem cell storage services.

Under the re-seller model, the tie-up should generate £50 per sale (after commissions and reinsurance costs)

 

View full WDC profile

WideCells Group Timeline

Newswire

WideCells expands its reach to Spain

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.